Pharmacokinetic Study of PF-06882961 in Participants With Type 2 Diabetes Mellitus With Varying Degrees
of Renal Impairment and in Participants Without Renal Impairment. A Phase 1, Open-Label, Single-Dose, Parallel Group Study to Evaluate the Pharmacokinetics of PF-06882961 in Participants With Type 2 Diabetes Mellitus With Varying Degrees of Renal Impairment Relative to Participants Without Renal Impairment.